INSULET (GOV BE) stock market data APIs
€273.3642
0(0%)
as of September 18, 2025
Try our APIs with
free plan!
INSULET Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for GOV.BE.
Prev. Close
273.3642
Open
273.3642
High
273.3642
Low
273.3642
52 wk Range
205.1-299.9
Market Cap
16 032 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get INSULET data using free add-ons & libraries
Get INSULET Fundamental Data
INSULET Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
INSULET News
New
Insulet Corporation (PODD) Benefited from Omnipod Sales
ClearBridge Investments, an investment management company, released its “ClearBridge Select Strategy” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. U.S. equitie...
Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette
From Pod to Pantone: Omnipod Mango becomes an iconic color First of its kind collaboration celebrates individualism and a personal journey toward empowerment for people living with diabetes ACTON, Ma...
Why Insulet (PODD) Shares Are Falling Today
What Happened? Shares of insulin delivery company Insulet Corporation (NASDAQ:PODD) fell 4.3% in the morning session after the company announced a change in its chief financial officer, a move that a...
Medical device maker Insulet taps industry veteran Flavia Pease as CFO
(Reuters) - Medical device maker Insulet on Tuesday named former Charles River Laboratories executive Flavia Pease as its new chief financial officer, succeeding Ana Maria Chadwick effective September...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
